Patient : KALYANI.P.S SID No.

: 05033085
Age / Sex : 47 Y / Female Reg Date & Time : 07/11/2019 07:33:15
Referrer : ADYAR CANCER INTITUTE Coll Date & Time : 07/11/2019 07:52:01
Branch : VELACHERY Report Date & Time : 07/11/2019 11:49:38

INVESTIGATION / METHOD RESULT UNITS BIOLOGICAL REFERENCE INTERVAL

IMMUNOLOGY

THYROID PROFILE TEST - TOTAL

Total-T3 (Triiodothyronine-T3) 86.9 ng/dl 70-204
( Method : CLIA) Pregnancy:
( Specimen: SERUM) 1st Trimester:81-190
2nd&3rd Trimester:100-260
Total-T4 (Thyroxine T4 ) 6.5 ug/dl 5.5-11.0
( Method : CLIA)
( Specimen: SERUM)

TSH (Thyroid-stimulating hormone) 14.19 uIU/ml 0.4-4.50

( Method : CLIA) 1st Trimester:0.3-4.5
( Specimen: SERUM) 2nd Trimester:0.5-5.6
3rd Trimester:0.8-5.2

INTERPRETATION:

In Pregnancy
TT3
1 Trimester 81 - 190 ng/dL
2 & 3 Trimister 100 - 260 ng/dL
TSH:
(As per American Thyroid Association)
1 Trimester 0.10 - 2.5 µlU/mL
2 Trimester 0.2 - 3.00 µIU/mL
3 Trimester 0.3 - 3.00 µlU/mL
- Assay results should be interpreted in context to the clinical condition and associated results of other investigations. -
Previous treatment with corticosteroid therapy may result in lower TSH levels while thyroid hormone levels are normal
- Results are invalidated if the client has undergone a radionuclide scan within 7-14 days before the test. - Abnormal
thyroid test findings often found in critically ill clients should be repeated after the critical nature of the condition is
resolved. - The production, circulation, and disposal of thyroid hormone are altered throughout the stages of
pregnancy.

End of the Report

Dr.M.V.R.MADHAVI MD.,
Biochemist

Page : 1 of 1